- Home
- INBS vs ALZN Comparison
INBS vs ALZN Comparison
Compare INBS & ALZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INBS
- ALZN
- Stock Information
- Founded
- INBS 2016
- ALZN 2016
- Country
- INBS United States
- ALZN United States
- Employees
- INBS N/A
- ALZN N/A
- Industry
- INBS Medical Specialities
- ALZN Medicinal Chemicals and Botanical Products
- Sector
- INBS Health Care
- ALZN Health Care
- Exchange
- INBS Nasdaq
- ALZN Nasdaq
- Market Cap
- INBS 6.3M
- ALZN 7.0M
- IPO Year
- INBS N/A
- ALZN 2021
- Fundamental
- Price
- INBS $1.30
- ALZN $1.11
- Analyst Decision
- INBS
- ALZN Strong Buy
- Analyst Count
- INBS 0
- ALZN 1
- Target Price
- INBS N/A
- ALZN $32.00
- AVG Volume (30 Days)
- INBS 132.7K
- ALZN 174.7K
- Earning Date
- INBS 02-07-2025
- ALZN 12-31-2024
- Dividend Yield
- INBS N/A
- ALZN N/A
- EPS Growth
- INBS N/A
- ALZN N/A
- EPS
- INBS N/A
- ALZN N/A
- Revenue
- INBS $3,187,974.00
- ALZN N/A
- Revenue This Year
- INBS $280.88
- ALZN N/A
- Revenue Next Year
- INBS $126.26
- ALZN N/A
- P/E Ratio
- INBS N/A
- ALZN N/A
- Revenue Growth
- INBS 55.29
- ALZN N/A
- 52 Week Low
- INBS $1.00
- ALZN $1.06
- 52 Week High
- INBS $11.70
- ALZN $15.06
- Technical
- Relative Strength Index (RSI)
- INBS 36.48
- ALZN 34.55
- Support Level
- INBS $1.20
- ALZN $1.16
- Resistance Level
- INBS $1.69
- ALZN $1.33
- Average True Range (ATR)
- INBS 0.12
- ALZN 0.09
- MACD
- INBS -0.04
- ALZN 0.01
- Stochastic Oscillator
- INBS 19.61
- ALZN 17.86
About INBS Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company business through two operating segments include Commercially available Intelligent Fingerprinting Products (IFPG or IFPG segment) and, Development Stage Biosensor Platform Technology (BPT segment).
About ALZN Alzamend Neuro Inc.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.